← Product Code [EJJ](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EJJ) · K973086 # PLA-96P (K973086) _Southern Dental Industries, Inc. · EJJ · Oct 7, 1997 · Dental · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EJJ/K973086 ## Device Facts - **Applicant:** Southern Dental Industries, Inc. - **Product Code:** [EJJ](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EJJ.md) - **Decision Date:** Oct 7, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 872.3070 - **Device Class:** Class 2 - **Review Panel:** Dental - **Attributes:** Therapeutic ## Indications for Use Silver based alloy dental restorative used in all classes of restorations. ## Device Story PLA-96P Admix Alloy is a silver-based dental restorative material. It is intended for use by dental professionals in clinical settings for the restoration of teeth across all cavity classes. The device functions as a filling material to repair tooth structure. It is applied by a dentist or dental professional during restorative procedures to restore tooth function and aesthetics. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Silver-based dental alloy; restorative material; form factor suitable for dental cavity filling. ## Regulatory Identification Dental amalgam is a device that consists of a combination of elemental mercury, supplied as a liquid in bulk, sachet, or predosed capsule form, and amalgam alloy composed primarily of silver, tin, and copper, supplied as a powder in bulk, tablet, or predosed capsule form, for the direct filling of carious lesions or structural defects in teeth. This device also includes the individual component devices, mercury and amalgam alloy, when intended to be combined with each other to form dental amalgam. ## Special Controls *Classification.* Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Dental Amalgam, Mercury, and Amalgam Alloy.”*See* § 872.1(e) for the availability of this guidance document. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the caduceus. The logo is black and white. OCT - 7 1997 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856 Ms. Samantha J. Cheetham Official Correspondent Southern Dental Industries, Incorporated 246 First Street, Suite 204 San Francisco, California 94105 K973086 Re : PLA-96P Trade Name: Regulatory Class: II Product Code: EJJ Dated: Auqust 14, 1997 Auqust 18, 1997 Received: Dear Ms. Cheetham: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ದ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Requlation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Reqister. Please note: this response to your premarket notification submission does not affect any obligation you miqht have under sections 531 {1}------------------------------------------------ Page 2 - Ms. Cheetham through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fida.gov/cdrh/dsmamain.html". Sincerely yours, K.J. Childers thy A. Ulatowski Timo Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health . Enclosure {2}------------------------------------------------ 510(k) Number (if known): K973086 Device Name: PLA-96P Admix Alloy Indications For Use: Silver based alloy dental restorative used in all classes of restorations. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) *Susan Remer* | (Division Sign-Off) | | |----------------------------------------|---------| | Division of Dental, Infection Control, | | | and General Hospital Devices | | | 510(k) Number | K973086 | | Prescription Use:
(Per 21 CFR 801.109) |
✓
| OR | Over-The-Counter Use: | |-------------------------------------------|-------------------------------------------------------------------|----|-----------------------| |-------------------------------------------|-------------------------------------------------------------------|----|-----------------------| (Optional Format 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EJJ/K973086](https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/EJJ/K973086) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com